TASHA RAMOS: Open Payments
NPI 1629422324 · HARTFORD, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$480 in 16 payments from 9 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $480
Food & beverage: $480
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 1 | $121 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 4 | $93 |
| Phathom Pharmaceuticals, Inc. | 3 | $54 |
| Ardelyx, Inc. | 2 | $48 |
| Gilead Sciences, Inc. | 2 | $41 |
| Aimmune Therapeutics, Inc. | 1 | $32 |
| Novo Nordisk Inc | 1 | $32 |
| QOL Medical, LLC | 1 | $30 |
| Madrigal Pharmaceuticals | 1 | $29 |
Products named: OMVOH, XIFAXAN, VOQUEZNA, IBSRELA, ZENPEP, Wegovy, Sucraid, REZDIFFRA.
Industry payments across CT — which companies pay providers there.
